Abstract
Endothelial dysfunction is considered to be a pre-clinical stage of atherosclerosis and represents an initial step of plaque progression. The aim of this study is to investigate whether the overproduction of biochemical markers is related to vascular damage. We studied 72 patients split into three groups:
20 patients had no vessels significant disease;
18 patients had multi-vessels disease;
34 patients had multi-vessels disease and stenosis >50%.
Patients with known coronary artery disease, stroke, hypertension, diabetes and/or dyslipidemia were excluded from the study.
We measured plasma levels of vWF (a marker of endothelial stress), VEGF (a marker of neointimal proliferation), TF and E-selectin (a marker of endothelial activation), all were measured by ELISA, and we investigated if their increased levels are related to the endothelial damage (table 1).
Table 1.
No disease . | Multi vessels . | Multi vessels disease+stenosis . | |
---|---|---|---|
vWF (IU/dl) | 84–102 | 128–154 | 146–182 |
VEGF (pg/ml) | 28–124 | 120–180 | 160–240 |
TF (pg/ml) | 16–98 | 80–220 | 230–370 |
E-Selectin (ng/ml) | 30–74 | 72–96 | 94–128 |
No disease . | Multi vessels . | Multi vessels disease+stenosis . | |
---|---|---|---|
vWF (IU/dl) | 84–102 | 128–154 | 146–182 |
VEGF (pg/ml) | 28–124 | 120–180 | 160–240 |
TF (pg/ml) | 16–98 | 80–220 | 230–370 |
E-Selectin (ng/ml) | 30–74 | 72–96 | 94–128 |
There is a significant relation between vWF, VEGF, TF and E-Selectin and vessels disease severity; patients with no vessels disease had an average thickness of 0.48 mm, (IMT: 0.6–1.18mm), patients with multi vessels disease had a median atheroma score of 1.12, (IMT:1.18–2.42mm), patients with multi vessels disease and stenosis had a mediam atheroma score of 2.40, (IMT:>2.42mm), indeed we did not find any significant relation between increased arterial stiffness and laminar shear-stress. Healthy endothelium exerts a favourable and athero-protective effects by a numbers of factors.
Table 2. Favorable and Atheroprotective Effects of the Healthy Endothelium
Promotion of vasodilation . |
---|
Antioxidant effects |
Anti-inflammatory effects |
Inhibition of leukocyte adhesion and migration |
Inhibition of smooth muscle cell proliferation and migration |
Inhibition of platelet aggregation and adhesion |
Anticoagulant effects |
Profibrinolytic effects |
Promotion of vasodilation . |
---|
Antioxidant effects |
Anti-inflammatory effects |
Inhibition of leukocyte adhesion and migration |
Inhibition of smooth muscle cell proliferation and migration |
Inhibition of platelet aggregation and adhesion |
Anticoagulant effects |
Profibrinolytic effects |
Table 3. Risk factors and predictors of endothelium dysfunction
Recruiment of inflammatory cells . |
---|
SMC proliferation |
Neointimal formation |
Oxidative stress |
Activation of procoagulant activities |
Activation of plateolet adhesion and aggregation |
Stasis of blood flow |
Recruiment of inflammatory cells . |
---|
SMC proliferation |
Neointimal formation |
Oxidative stress |
Activation of procoagulant activities |
Activation of plateolet adhesion and aggregation |
Stasis of blood flow |
In conclusion, we demonstrated that high levels of vWF, VEGF, TF, E-Selectin may play a critical role as for the development and the progression of atherosclerosis, even if further and wider studies are needed to confirm this statement.
Disclosures: No relevant conflicts of interest to declare.
Author notes
Corresponding author
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal